Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Clinical trial NCT04877691 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04877691
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2021-06-08
Primary completion: 2025-08-22
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.